McKesson Co. (NYSE:MCK) Shares Sold by Vima LLC

Vima LLC cut its stake in McKesson Co. (NYSE:MCK) by 9.4% during the 3rd quarter, HoldingsChannel reports. The fund owned 471 shares of the company’s stock after selling 49 shares during the period. Vima LLC’s holdings in McKesson were worth $233,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. LRI Investments LLC acquired a new stake in shares of McKesson during the first quarter worth $28,000. Register Financial Advisors LLC bought a new position in shares of McKesson during the first quarter worth about $29,000. Wolff Wiese Magana LLC grew its position in shares of McKesson by 742.9% during the third quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock worth $29,000 after acquiring an additional 52 shares during the last quarter. ORG Wealth Partners LLC bought a new position in shares of McKesson during the third quarter worth about $40,000. Finally, ZRC Wealth Management LLC bought a new position in shares of McKesson during the first quarter worth about $48,000. 85.07% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Brian S. Tyler sold 3,753 shares of McKesson stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $561.10, for a total value of $2,105,808.30. Following the transaction, the chief executive officer now owns 78,586 shares of the company’s stock, valued at $44,094,604.60. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.11% of the company’s stock.

Wall Street Analyst Weigh In

MCK has been the subject of several recent research reports. Evercore ISI lowered their price target on shares of McKesson from $660.00 to $630.00 and set an “outperform” rating for the company in a research report on Thursday, August 8th. JPMorgan Chase & Co. upped their price target on shares of McKesson from $656.00 to $661.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 21st. Robert W. Baird reiterated a “neutral” rating and issued a $531.00 target price (down previously from $603.00) on shares of McKesson in a research report on Tuesday, September 24th. Wells Fargo & Company decreased their target price on shares of McKesson from $576.00 to $535.00 and set an “equal weight” rating for the company in a research report on Friday, September 13th. Finally, Barclays increased their target price on shares of McKesson from $596.00 to $616.00 and gave the company an “overweight” rating in a research report on Thursday, August 8th. Five investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $610.86.

McKesson Stock Performance

Shares of MCK stock traded up $1.06 during trading on Monday, hitting $508.47. 116,751 shares of the company were exchanged, compared to its average volume of 799,958. The firm has a market capitalization of $65.94 billion, a price-to-earnings ratio of 22.69, a P/E/G ratio of 1.18 and a beta of 0.44. The business’s 50-day simple moving average is $516.67 and its 200 day simple moving average is $551.19. McKesson Co. has a twelve month low of $431.35 and a twelve month high of $637.51.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, August 7th. The company reported $7.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.21 by $0.67. The firm had revenue of $79.28 billion during the quarter, compared to analysts’ expectations of $82.53 billion. McKesson had a net margin of 0.94% and a negative return on equity of 242.57%. The company’s revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the company earned $7.27 earnings per share. On average, equities analysts forecast that McKesson Co. will post 31.91 earnings per share for the current fiscal year.

McKesson Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, October 1st. Stockholders of record on Monday, September 2nd were given a $0.71 dividend. This is a positive change from McKesson’s previous quarterly dividend of $0.62. The ex-dividend date of this dividend was Friday, August 30th. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.56%. McKesson’s dividend payout ratio (DPR) is currently 12.70%.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.